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Several studies have shown that research participants who have consented to

participate in a study often have limited comprehension of the information presented in
the informed consent process. This study compared performance on an end-of-study
consent document information retention measure between a

read-and-sign consent

procedure control group and an enhanced consent procedure experimental group. The
enhanced consent procedure consisted of a pre-consent educational module and a

question-and-answer style consent document. The control group scored an average of
78.7% correct on the multiple-choice question measure of participant retention of
information contained within the consent documents. The experimental group scored an

average of 92.3% on that measure, a statistically significant difference. These findings
suggest that participants who experienced the enhanced consent procedure retain more
information from the consent documents than those who experienced the typical consent

procedure. A more highly informed participant pool may fulfill some of aspirational and
ethical goals of our field but the side effects of reaching that goal are unknown.
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INTRODUCTION

Informed consent is a foundational component of Federal and ethical guidelines

on the protection of human research participants (Belmont Report, 1979). Informed
consent has been conceptualized as having three primary considerations (Alkhatib, 2008;
Barnett, Wise, Johnson-Greene & Bucky, 2007; Lidz, 2006). Potential participants must

be provided with adequate information about the research protocol in a format that

promotes understanding. Potential participants must be capable of understanding the
information. Finally, they must be making the decision to participate in a coercion-free
environment, as advocated by Ethical Principles of Psychologists and Code of Conduct

(American Psychological Association [APA], 2002) and required by Federal Law
(Protection of Human Subjects, 45 C.F.R. § 46.116, 2009). Empirically evaluating and
improving the informed consent process is fundamental to achieving the human subject
protections advocated in professional codes of conduct, and in Federal and institutional
human subjects regulations. (Agre et al., 2003).

Assessing the Level of Understanding of the Consent Process

HSIRB guidelines typically require the execution of an informed consent process

prior to the enrollment of a participant in a study. Although the exactelements may vary
across research projects, an informed consent often includes a written or verbal

explanation of 1)the purpose of the study, 2) the expectations for participants 3) the risks,
benefits and protections for study participants; 4) the obligations of the researchers to the

participants and 5) the rights of the participants. While the goal of the informed consent
process is to ensure that all potential participants to make a decision that is truly
informed, there is reason to be concerned about the extent to which participants truly

comprehend the crucial details that are included in a typical informed consent process.

For example, Agre and Rapkin (2003) found that participants scored an average of 68.3%
correct on a test of the content of a typical informed consent document (Agre & Rapkin,

2003). Participants in a hypertension clinical trial scored an average of 71.6% correct on

a multiple-choice knowledge test two hours post consent and 61.2% three months post
consent (Bergler, Pennington, Metcalfe, & Freis, 1980). Chanaud, Merlani, Luyasu, and
Ricou (2006) found that only 32% of ICU patients who had participated in a clinical trial
were able to recall the purpose of the clinical trial or the associated risks (Chanaud,

Merlani, Luyasu, & Ricou, 2006). A number of other researchers have documented that

research participants demonstrate relatively poor comprehension of the details and risks
of a study, in spite of completing and signing off on an informed consent process

(Everett, Novoseletsky, Cole, Frank, Remillard, & Patal, 2005; Falagas, Korbila,
Giannopoulo, Kondilis, & Peppas, 2009; Joffe, Cook, Cleary, Clark, & Weeks, 2001;
Rounsaville, Kunkele, Easton, Nich, & Carroll, 2008; Wirshing, Wirshing, Marder,
Liberman, & Mintz, 1998). The degree of understanding of consent documents shown by

participants of clinical trials may not be satisfactory, although there are few evidencebased benchmarks for determining what a "satisfactory" level of understanding might be

(Falagas et. al., 2009). Given the ethical and legal requirements for informed consent,
these findings suggest that more effort should be focused on improving participant

understanding of informed consent materials.
Interventions Suggested by the Literature

It has been suggested that assessment of potential participant's understanding of a

study should be a standard part of the informed consent procedure (Agre et al., 2002)
because it improves participant understanding of research protocols. Surveys about the
information contained in the informed consent documents have been used to assess

immediate retention of those materials (Agre & Rapkin, 2003). Repeated assessment with
corrective feedback has been shown to significantly increase scores on consent document

knowledge surveys (Sudoe, Landefeld, Williams, Barnes, Lindquist & Schillinger, 2006).
Informing participants of a scheduled post-consent comprehension assessment also

produces higher levels of comprehension than a consent process that excluded the a priori
announcement of a comprehension assessment, even when the time allocated to study of
the informed consent was doubled (Matlin, 2009).

Education about the purposes for the informed consent process prior to exposure
to the informed consent document may also improve participant understanding of a

research protocol. Schizophrenia patients who received pre-consent education about the

goals of the informed consent process showed larger increases in comprehension of
consent details than those patients who received the same informed consent process but

without pre-consent education. (Wirshing, Sergi & Mintz, 2005). These results are
sufficiently robust that some Phase I Clinical Trials have implemented a pre-consent
educational module regarding the purpose of informed consent procedures (Kim, Young,

Neimeyer, Baker & Barfield, 2008).

Several categories of information regarding a research protocol are typically

identified as important areas for inclusion in consent documents. This includes: voluntary

participation, purpose of the study, reasons for the study, risk and benefits, treatment
alternatives, rights to withdraw, confidentiality of data, and who to contact with questions

or problems (Angeles-Llerenas, Wirtz & Lara-Alvarez, 2009; Lansimies-Antikainen,
Piertila, Laitinen, Schwab, Rauramaa & Lansimies, 2007; Porteri & Bony, 2007;

Simonoff, 2003). The Informed Consent Educational Tool (ICET) covering the purposes
of informed consent and organization of the consent document used in this study is based

on these findings. These categories were also used to develop the Informed Consent

Comprehension Test (ICCT). These instruments are described in detail in the methods
section.

How to Study Participant Understanding of Consent Materials

Typically, efforts to study the informed consent process are affixed to an adjunct
research protocol on an unrelated topic. In this manner the informed consent process on

the separate topic can be the focus of the research efforts to assess or improve the
comprehension of the informed consent process. There are two main concerns about
research on informed consent processes, the availability of adjunct studies and the use of

vulnerable participants. Recruitment of clinical populations for clinical trials is difficult

(Agre, Rapkin, Dougherty & Wilson, 2002). It has been assumed that examination of
consent procedures would harm recruitment rates for adjunct studies, an important
consideration for research protocols with stringent inclusion and exclusion criteria or
those studies which focus on low-base rate disorders. A review of informed consent

studies in the literature did not reveal any change in recruitment rates in adjunct studies

(Agre et al., 2003). However, in order to alleviate some of the recruitment difficulties that
clinical trials have with low numbers of participants, some attached informed consent

studies make use of surrogate participants (Agre & Rapkin, 2003). Surrogate participants

are those who would not be eligible for the adjunct studies and, as a nonclinical

population, are easier to find and recruit. Surrogate participants have been found to
perform less well on assessments of understanding of informed consent materials than
clinical populations involved in adjunct studies, or those patients' families (Agre &
Rapkin, 2003). As a non-clinical, easy to find population, with minimal inclusion or
exclusion criteria, surrogate participants share many of the qualities that make

undergraduate students and Internet recruits attractive as sample populations for research.
Despite much of the literature for informed consent being conducted with randomized
clinical trial participants, college- and internet-recruited samples share many of the same
properties as surrogate participants.
The Adjunct Study: Application of Critical Thinking Guidelines to the
Evaluation of Health Claims

Consumers are beset with marketing for products, services, and other claims, for

which scientific support is often lacking or contradictory. Many have suggested that
consumers need to be armed with "critical thinking skills" to help them evaluate the

evidentiary base for such claims and to help them select products and services that are
most likely to deliver the advertised benefits and least likely to produce dangerous or
unwanted side effects. For example, when a person is diagnosed with hypertension they
are faced with a plethora of treatment options. Some of these options have overwhelming

empirical support for their effectiveness, such as diuretics, beta-blockers, or lifestyle
changes, while others lack suchsupport, as withtoxincleansing treatments or joint-health
bracelets. Persons who choose the latter options are failing to discriminate between

treatments with sufficient evidentiary support and those treatments which either lack

sufficient evidentiary support or contain misleading and contradictory evidentiary
support.

Deficits in the critical thinking skill set are not uncommon. Eisenberg (1993,

1998) surveyed Americans in order to assess alternative medical treatment use, defined as
treatments not included in medical school curricula or generally offered in hospitals.

They found that 42% of their 1997 sample used at least onetype of alternative therapy in
the previous year, an increase over the 33.8% of those in a 1990 sample who used
alternative therapies. MacLennan found similar numbers of alternative therapy consumers

(52%) in a 2006 survey of Australians. The rates of usage are dramatically higher

amongst vulnerable populations. Patterson (2002) found that 70% of participants in a
sample of American cancer patients had used at leastone type of alternative therapy in
the pastyear. Rates of usage were highest for women, younger individuals, those with
more years of education, and those participants of higher socioeconomic status

(Patterson, 2002). The annual expenditure on alternative medical treatments in the United
States is over 34 billion dollars (Herman, 2005). This is a substantial monetary
investment in treatments that have little or no empirical support (Barnes et al., 2002).

Several people have offered guidelines to help consumers evaluate the
believability of claims based on standards of evidence. For example, in his book The

Demon Haunted World, Sagen described the Baloney Detection Kit (Sagen, 1996, p.

210), a set of guidelines for discriminating between evidentiary claims and faulty claims.
In a similar manner, Shermer describes 25 fallacies that lead to faulty decision making

(Shermer, 1997, p. 44) and supplies a series of questions to guide the evaluation of
various claims such as: have the claims been verified by another source; how does the

claim fit in with how we know the world works. While these guidelines are helpful in

evaluating the scientific credibility of various claims, they have not been subject to

experimental evaluation with regard to their impact on the "believability" of various
claims and a person's willingness to take action based on the claims (e.g., to purchase or
use a product based on such claims).

The goal of the adjunct study was to evaluate the effects of a critical thinking
checklist on the believability of unsupported medical treatments. The adjunct study, while

interesting in and of itself, provides a vehicle to the primary study, an analysis of

participant comprehension of the informed consent protocol for the adjunct study. The
results of the adjunct study will be reported elsewhere.

METHODS

Participant Recruitment

In order to be eligible for this study, the potential participants had to be over the

age of 18. Minors were excluded because their participation would require the consent of
a guardian as well as the minor's assent thus diverting focus from the consent process that
is typically used with competent adults. There were no exclusionary criteria for potential

participants; there was an implicit requirement that participants have access to the
Internet for the purpose of completing on line surveys.

Participants were recruited using four methods, the first three of which were

implemented on the Western Michigan University campus. The first method involved

posters (Appendix L) displayed in academic buildings on campus. The second method
involved presentations using PowerPoint slides in undergraduate classes (see Appendix K
for the presentation script). The third method used Sona Systems, a commercial

participant recruitment software package, to contact participants who registered on the
Western Michigan University Sona Systems database (seeAppendix M for the Sona

Systems application form). The first three methods were intended to recruit students
attending Western Michigan University (WMU). The fourth method was Facebook
advertisement (see Appendix N for a screen shot of the Facebook advertisement)
Participant Descriptions

While 74 individuals consented to participate in this study, there were 37 women,

19 men and one transgendered individual who completed the study. A total of 17
individuals dropped at various stages of the study, eight participants from the

experimental group, two participants from the control group and 7 individuals who
withdrew before being sorted. One woman was recruited via Facebook, while the rest
were recruited from WMU. Participants who were university students reported an

average GPAof 3.21. Participants were between 18 and 51 years old with a mean age of
21.86 years.

Instrumentation

The Research Protocol Map (Appendix A) is included as a visual counterpart to

the prose explanations of this study's design. It shows the path that participants take
through the study, diverging down different paths for control and experimental groups.
The Informed Consent Educational Tool (ICET; Appendix B) is a brief set of
informational slides that contain information on the purposes and conceptual foundations

of the informed consent process for human participant research. The information
contained on these slides is similar in nature to the information contained within the

question-format consent template provided by the WMU Human Subjects Institutional
Review Board. Participants were shown the slides in sequence on the survey, being

required to click a button labeled 'Read this slide" to advance to the next slide.
Participants were shown a total of 12 slides, three of which are represented below.
Slide 1
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Slide 4
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Slide 7
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Following completion of the ICET, participants in the experimental group began
the first section of the consent form. In order to address the risk of having participants

exposed to research manipulations before consenting, each slide of the ICET had the
following disclaimer about a participant's right to withdraw from the study, "You have the

right to withdraw from this study at any time, you can accomplish this by closing your
browser window. Your information will not be saved."

The Informed Consent Comprehension Test (ICCT) is a pair of 15 multiple-choice

question surveys. Form 1 of the ICCT (Appendix C) is used piecemeal during the
modified consent procedure, its' questions positioned sequentially with sections from the
consent form for this study. Only the Experimental Consent Group participants were

exposed to Form 1 of the ICCT. Form 2 of the ICCT (Appendix D) was given to all

participants following completion of the medical claim vignettes and believability index
iterations. Form 2 of the ICCT contains questions about similar content as was covered in

Form 1 but the questions are phrased differently and as a result, the correct answers differ
from Form 1 to Form 2. Form 2 of the ICCT was administered at the end of the adjunct

study and allows for about one hour between presentation of the consent document
information and retention assessment.

The Demographic Survey includes questions concern gender, education level,

GPA during last education, age, and WMU enrollment status (Appendix E). These data
were used for describing the participant sample and as mediating variables.
Revised Paranormal Belief Scale (RPBS; Tobacyk, 2004; Appendix F.) is a 26-

item measure of paranormal beliefs. The RPBS is designed to measure an individual's

10

degree of beliefon seven dimensions: Traditional Religious Beliefs, Psi, Witchcraft,
Superstition, Spiritualism, Extraordinary Life Forms, and Precognition. Participants were
asked to rate their belief in statements (e.g. The number '13' is unlucky, Some psychics

can accurately predict the future.) on a seven point Likert-scale, ranging from "strongly

disagree" to "strongly agree" with a central score meaning uncertain or neutral. The
RPBS includes questions about an individual's religious beliefs alongside questions about

paranormal beliefs; this may have caused discomfort for some participants. In orderto
assuage some of this possible discomfort, the following phrase has been added to the top
of the measure: "There are no right or wrong answers, this is a sample of your own
beliefs and attitudes. This study does not presuppose that some beliefs are correct or
incorrect, rather that individuals differ in what beliefs they have."

A Personal Belief Scale (Appendix G) was developed for this study and included

15 original items designed to assess the participant's belief in different alternative and

complementary medical treatments. Participants were shown statements (e.g. Dietary
changes can affect a person's cholesterol levels, or Hypnotic suggestion is an effective
way to bring about weight loss.) and were then asked to rate their belief in that statement
on the same Likert scale described above.

The Medical Claims Vignettes (Appendix H) are a set of five hypothetical directto-consumer medical advertisements adapted from existing advertisements. The original
advertisements were modified, to obscure the identity of the product or treatment. The

intent was to present each vignette as a novel advertisement for which each participant
was to judge based solely on the information contained within the claim, not on their long
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history of exposure to information aboutalternative medical treatments such as hypnosis
or massage therapy. An example a de-identified advertisement for herb-based toxin
cleansing footpads appears as Vignette 4.
Vignette 4

The genius' breakthrough is one in which he or she escapes the
rigidities of the normal and tired patterns of thought—
unconventionality is one great measure of brilliance. One such

example of an all-natural productof unconventional (but no doubt
effective) thought is the concept of Treatment 4 by Brand Zero.
Treatment 4 is a very effective treatment, which uses only natural
herbs, allowing for the body's complete response to Condition 4.
Spoke S. Person, who is almost a century old, is the eager

spokesperson of the product, and thus becomes the perfect testament
for Treatment 4 claim to healthy living.

Each portion of Treatment4 contains vegetable fiber, vitamin C,
dextrin, loquat leaves, chitosan, tourmalines, houttuynia coddata, and
bamboo and wood vinegars. Treatment 4 is manufactured in Asia
where most of its natural ingredients are harvested. Treatment 4 is

applied to the area affected by Condition 4 at least 8 hours every
night, although sometimes longer applications might be necessary

depending on an individual's body chemistry. The aforementioned
ingredients then all work together, to help the body alleviate the
cause of Condition 4. Quite simply, Treatment 4 works.

The Believability Index is a 3-item survey designed to measure the degree to
which the treatment described in each vignette seems like a "good choice." The specific
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questions are: I believe that Treatment X is effective in the treatment of Condition A. I
would choose Treatment X if I had Condition A. If a friend or family member had

Condition A, I would not recommend Treatment X. Participants are asked to rate how

muchthey agree with the statement on a 7 point Likert-scale spanning completely

disagree to completely agree, with a central ranking being uncertain. This measure is
attached in Appendix I.

The Critical Information Checklist (CIC; Appendix J), is a 16-item checklist that

was intended to assist participants in identifying pseudoscientific medical claims. There
are four domains on this checklist, each containing four questions. The first domain is

Authority, which includes questions on the source of evidence for claims made (e.g. Does
the claim suggest their productor treatment is well known elsewhere but is actively
hidden by stronger competitors here?). The seconddomain is Logic, which includes

questions about the logical consistency of claims made, including; Does this claim
suggest that findings that are currently unexplained or will be never be explainable?. The
third domain is Non-Evidence, which includes questions about the legitimacy of evidence

presented in support of claims made (e.g. Doesthis claim use personal anecdotes as a
substitute for scientific research?). The fourth domain is Language Use. This domain

includes questions such as; "Does the person or organizationmaking this claim hide
behind complex words or language to mask the lack of evidence behind their claim? For
example, "When asked about the source of her powers, a local psychic explained that

quantum mechanics provide the power behind her clairvoyant abilities." Many items
include examples of the error such as the psychic mechanics example. Participants were
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asked to answer the 16 checklist items with Yes, No, or Not Relevant, for each of the five
medical claims vignettes.

The consumer satisfaction survey (Appendix K) is a 4-item questionnaire that was

intended to measure the participant's experience with the consent procedure they

experienced at the beginningof the study. The questions are:
•

How difficult do you think this consent procedure was?

•

How informed about this study do you feel as a result of this informed consent
process?

•

How useful do you feel this informed consent procedure was?

•

What is your overall impression of the informed consent process?

Participants answered each question using a 7-point Likert scale that ranged from the
opposing extremes at one and seven, with the neutral response at four.
Participant Protections

There were several slight risks for participating in this study. The first was the

purposefully vague explanation of the manipulations to the informed consent process for
the experimental group. This was done to hide the measurement of participant's retention
of material from the consent document. It was our concern that if participants were fully

informed as to the nature of those measurements, they may have had paid special

attention or used remembering tactics they might otherwise not have used when they

were reading the consent document. Instead potential participants were informed that "A
secondary purpose of this study is to explore the effects of a modified consent

procedure." and that part of the requirements of participation is "...be exposed to one of
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two different consent procedures." In this manner, participants were not explicitly told the
details of the experimental manipulation. Participants were informed about this

deception and the rationale for it, following completion of the study. The debriefing script
is attached in Appendix L.

The second minor risk is based on some of the questions from the Personal

Beliefs Scale, which posed questions about beliefs in magic and monsters adjacent to

questions about beliefin a God or a Devil. Participants may have felt anxiety or insulted
if they felt we were putting commonly held religious beliefs in the same category as
beliefs about supernatural phenomena. We attempted to address this risk by placing the

following disclaimer at the top of the Personal Beliefs Survey: "There are no right or
wrong answers, this is a sample of your own beliefs and attitudes. This study does not

presuppose that some beliefs are correct or incorrect, rather that individuals differ in what
beliefs they have."

The third portion of this study that posed potential risks to participants is the use
of the Informed Consent Educational Tool, which was presented before participants had

formally consented to participate in the study. In order to addressthis issue without

breaking the deception regarding the informed consent manipulation, each slide of the
ICET had a disclaimer attached that informed potential participants of their right to

withdraw from the study at any time. This disclaimer read "You have the right to
withdraw from this study at any time, you can accomplish this by closing your browser
window. Your information will not be saved."
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Experimental Procedures and Design

The participant flow chart in Appendix A provides a graphical representation of

the experimental procedures and participant flow for this study. All potential participants
from WMU were referred to the Sona Systems participant recruitment software. The

Sona Systems advertisement provides some basic information about the study and
funneled interested individuals to the study's web-based survey site. Potential participants

recruited through Facebook were also directed to the same web-based.
Once potential participants reach the study's Surveymonkey site, they were

randomly assigned to two groups, the standard consent control group and the enhanced
consent experimental group. The control group was exposed to the consent form for this

study (Appendix M) asked to read the consent form, and then click consent to continue or
clicking refuse/close the browser to refuse consent. The experimental group was first
asked to read the 12 slides comprising the ICET, this requires that participants click

continue after reading the each slide. Following the ICET the participant was shown the
consent form with each section separated by ICCT questions such as:

What are we trying to find out in this study?
In our information intensive, media saturated world, we are bombarded every

day with lots of health related information and claims. Some of these health
claims are accurate but, unfortunately other claims are unproven or, in some
cases, misleading. The primary purpose of this study is to assess the effect on
believability of medical claims as result of exposure to an evidence checklist.
A secondary purpose of this study is to explore the effects of a modified
consent procedure.

2. Which of the following is a purpose of this study?
a. Test a new PTSD survey
b. Assess differences in Medical Claims
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c. Test a Therapy Technique
d. Assess effects of Text Coloring

After reading each section, experimental group participants were asked to answer

related questions from the ICCT. Once participants had read all seven sections of the
consent form and answered the last set of ICCT questions each participant was given the

opportunity to click consent to continue or refuse to consent. Participants were told that
refusing to consent is accomplished by closingthe browser windowor by clicking the
refuse button.

Critical Thinking Methods

Following the control and experimental consent procedures, all participants were
asked to fill out a demographics survey, and the personal beliefs scale. The medical
claims control group was asked to read five medical claims vignettes and then complete a

believability index for each. The medical claims experimental group was asked to

complete a CIC for each of the medical claim vignettes in addition to the believability
indices. Following completion of the medical claim vignette iterations, all participants
were asked to complete Form 2 of the ICCT, and a consumer satisfaction survey

concerning the consent procedure they experienced. Following completion of all study
measures participants were debriefed, and fully informed of the deception related to the

consent procedure manipulations. Participants were encouraged to contactthe research if
they have any questions or concerns. After completion of the debriefing sequence

participants' browsers were rerouted to the web address of the "kitty hugging a bear" gif
file (Appendix N), the reward for completion of the study.
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Location of Data Collection

This study took place on the Internet, specifically the Surveymonkey website

(Surveymonkey.com, 2009). This website utilizes SSL encryption in order to ensure
secure transmission of responses from participants and of data to researchers.

Surveymonkey does not use the information gathered through use of their website and all
materials used are considered confidential and are handled as such. Data collected were

backed up daily on Surveymonkey servers, and all these data were stored in a password-

protected, SSL encrypted, electronic format. This website is Section 508 (29 U.S.C. '
794d) compliant, meaning that it is accessible to those with limited mobility and visual
sensory deficits. Participants were free to complete the study from any computer, and
were not restricted to certain labs, operating systems, or Internet browsers.
RESULTS

This study focused on the impact of strategies to enhance comprehension of
informed consent protocols. Even though data on the believability of various medical
claims were collected, they are not reported herein as that is not the focus of this

experiment. The primary dependent variable in this study was percentage of correct
responses regarding the content of the consent documents as measured by the ICCT
administered approximately one hour after the presentation of the informed consent
materials, as assessed by the ICCT. This was calculated as percentage correct, which was
compared between the experimental group and the control group, as depicted in (Table 1.)
The control group (n = 26) earned an average score of 78.71 percent correct on the ICCT,
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with a standard deviation of 15.66 and a range of 26.67 to 100 percent correct. The

experimental group (n = 31) earned an average score of 92.9 percent correct, with a
standard deviation of 6.42 and a range of 80 to 100 percent correct. There was a

difference of 14.19 percent correct between the group's mean scores on the ICCT and that
difference was significant at the .001 level (F = 21.223, p < .001).

Participants were split into gender specific groups to allow for within

experimental group comparisons. Only one individual self-identified as transgendered,
they were not included in this analysis due to the lack of a comparison group. For those

participants in the control group, women (n =17 ) earned an average score of 80.39
percent correcton the ICCT. Men (n = 8) earned an average score of 74.16 percent
correct on the ICCT. There was a difference of 6.23 percent correct between the two

subgroup's scores on the ICCT, but this result was not significant at the .05 level (F = .
543, p = .588).

For those participants in the experimental group, women (n = 20) earned an
average score of 92.33 percent correct on the ICCT. Men (n = 11) earned an average
score of 93.93 percent correct on the ICCT. There was a difference of 1.6 percent correct
between the two subgroup's scores on the ICCT, but this result was not significant at the .
05 1evel(F = .435,p = .515).

Participants were split into high and low GPAsubgroups for within experimental
group comparisons. The groups were split at 3.21, which was the average GPAfor all

participants. One participantdid not provide GPA data and was not included in this
analysis. For those participants of the experimental group, the high GPA subgroup (n =

]9

20) earned an average score of 92 percent correct on the ICCT. The low GPAsubgroup (n
= 10) earned an average score of 94 percent correct. There was a difference of 2 percent
correct between the two subgroup's scores on the ICCT, but this result was not significant
at the .05 level (F = .95, p = .39).

For those participants of the control group, the high GPA subgroup (n = 10)
earned an average score of 83.33 percent correct on the ICCT. The low GPAgroup (n =

16) earned an average score of 75.83 percent correct. There was a difference of 7.5
percent correctbetween the two subgroup's scores on the ICCT, but this result was not
significant at the .05 level (F = 1.435, p = .243).

Participants were also split into subgroups based upon their scores on the

paranormal beliefs portion of the personal beliefs scale. The groups were split at a score
of 81.51, the mean score for this participant sample. For control group participants, the

high belief subgroup (n = 17) earned an average score of 77.64 percent correct on the
ICCT. The low belief subgroup (n = 9) earned an average score of 80.74 percent correct.
There was a difference of 3.1 percent correct between the subgroup's scores on the ICCT,
but this was not significant at the .05 level (F = .222, p = .642).

For experimental group participants, the high belief subgroup (n= 11) earned an
average score of 91.51 percent correct on the ICCT. The low belief subgroup (n = 20)
earned an average score of 93.66 percent correct. There was a difference of 2.15 percent
correct between the group's scores on the ICCT, but this was not significant at the .05
level (F = .790, p = .381).

Finally, participants were split into subgroups based upon their scores on the
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medical beliefs portion of the personal beliefs scale. There was only one participant who

reported higher belief in unsupported medical claims than empirically supported medical
claims. Participants were split into groups based on the discrepancy between their

rankings of belief on the empirically supported subscale of the PBS and their rankings on

the unsupported subscale. Groups were split at the mean discrepancy of 1.83 points. For
control group participants, the high discrepancy group (n = 9) earned an average score of
82.96 percent correct on the ICCT. The low discrepancy group (n = 17) earned an average
score of 76.47 percent correct. There was a difference of 6.49 percent correct between the

group's scores on the ICCT, but this finding was not significant at the .05 level (F = 1.01,
p = .325).

For experimental group participants, the high discrepancy group (n = 20) earned
an average score of 93 percent correct on the ICCT. The low discrepancy group (n = 11)
earned an average score of 92.72 percent correct. There was a difference of .28 percent

correct between the group's scores on the ICCT, which was not significant at the .05 level
(F = .012,p = .912).

The consumer satisfaction survey was used to measure participant's experiences

with the experimental and standard consent procedures (Table 2). All of the control group

participants reported that the standard consent procedure was easy, while all but 3.2% of
the experimental group thought the modified consent procedure was easy. In the control

group 61.6% of participants reporting feeling informed about almost all or all aspects of
the research protocol as a result of the consent procedure, compared with 74.2% of the
experimental group. For control group participants, 84.6% felt that the consent procedure
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was at least somewhat useful, compared with 90.3% of the experimental group. When
asked of their overall impression of the consent procedure they experienced, 69.2% of

control group participants had a positive experience, compared with 74.2% of the control
group.

DISCUSSION AND FUTURE DIRECTIONS

The significant difference in performance on the ICCT between control and

experimental groups suggests that exposure to the modified consent procedure increases
retention of related information.. These findings also suggested that there was no

significant performance differences between subgroups based on gender, GPA,

paranormal beliefs, or medical beliefs. The lack of significant difference for confounding
variable subgroups suggests that the primary factor driving performance differences
between the control and experimental groups was the modified consent procedure.

The modified consent procedure was rated as slightly difficult by 3.2% of the

experimental group. The experimental consent procedure was also rated by participants
as more informing, more useful, and an overall more positive experience, when compared
with control group ratings of the standard consent procedure. This suggests that the
modified consent procedure is no more aversive to participants than standard consent
procedures, and may even be preferable.
There are several questions prompted by the results of this study. The enhanced
consent procedure involved a combination of two potentially active variables, a

component analysis may reveal whether the pre-consent educational tool or the duringconsent assessment was the primary driver of performance differences. It will also be
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important to look for additional variables that may contribute to performance on the
ICCT, such as past research experience or knowledge of research design. The mechanism
for advancing through the comprehension test could also be open for exploration, such as

requiring correct answers before participants can continue through the consent procedure.
While this enhanced consent procedure was successful at increasing participant

comprehension of consent materials, there is no empirical benchmark against which to

judge the value of this improvement. Additional research is neededto determine what
level of consent understanding, under what circumstances, is best. The level of participant
risk involved in a research protocol may be an important variable for determining

satisfactory levels of participant understanding. Perhaps 90% understanding would be

satisfactory understanding for high-risk research protocols, while 80% would be enough

for low-risk protocols. There may also be differential levels of understanding required for
different elements of the consent materials. Participant understanding of the risks and

benefits of a research protocol could be held to a higher standard than understanding of
the theoretical background of a protocol.

The enhanced consent procedure requires significantly more input from potential

participants than does the standard consent procedure. The relatively high response cost
of the enhanced consent procedure may have contributed to the higher rate of drop out in

the experimental group (25%) compared to the control group (7%). Future researchers
may want to focus on increasing the aesthetic and functional aspects of an enhanced
consent procedure to minimize any variables aside from high response cost that may
increase participant attrition.
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This study used gender, self-reported GPA, a measure of paranormal beliefs, and a
measure of medical beliefs as possible variables that could confound performance on the
ICCT. The latter two variables were convenient to use, as the data were collected for the

adjunct study. Future studies should focus on other more likely influential variables such
as reading level, past experience as a research participant, or education about research
methods.

The differential effects of participant understanding are not well understood.

Participants with a high degree of understanding about the research protocol may respond
differently than those with a low degree of understanding. Additional research is needed
to document and explore the corollary effects of increasing participants' understanding of
research protocols.

There are several improvements that could be made to the enhanced consent

procedure for future users. The response cost of coming up with a comprehension test
based on consent materials is quite high for researchers, and the development of a

comprehension questionnaire template could help. There is also a higher response cost in
terms of delivering the modified consent procedure, when compared with the low cost of

administering and collecting a signed form. In multi-language settings, translation of
consent materials could prove an additional barrier to adoption of the enhanced consent

procedure. A software delivery system for the modified consentprocedure may be able to
address the magnitude of the response cost problems and ease translation issues.
The results of this study suggest that the modified consent procedure produces
increased retention of information contained within the procedure than standard consent
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procedures, and that the modified procedure is comparable with the standard procedure in
terms of participant satisfaction. Despite high researcher response cost and a slight
increase in perceived difficulty of the consent procedure, this intervention can assist all
researchers in being able to better fulfill their ethical and legal requirements for gathering
informed consent. Future research and development may be able to alleviate the response

cost issues and promote adoption of this modified consent procedure.
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Informed Consent Educational Tool
Foundations of Informed Consent

•

Informed Consent has three requirements.

•

Information Disclosure

•

Capacity to Consent

•

Non-Coercive Environment

Providing potential participants with enough information to understand their role within a
research study.
• What they are expected to do

•

What they can expect as a result of participation

•
•
•

Risks and Benefits of Participation
Handling of their Confidential information
Ensuring that this information is understood.

•

Capacity to Consent

•

Potential Participants must be capable of understanding the information presented
to them.

•
•

Typically thought of as mental competency.
Children, Individuals with Mental Deficiencies, and Individuals with Dementia
are unable to consent, but instead give assent.

•

Which requires the consent of a parent or guardian.

Non-coercive Environment

•
•
•

Participation in a research study must be completely voluntary.
An individual must not be coerced into participation by removal of privileges
(prison populations) or with inordinate rewards (money to poor individuals.
The decision to participate should not be influenced by fear of loss.

Sections of an Informed Consent Document
Introduction

•

Should Contain Information about:

•

Why you are being invited to participate

•
•
•

Who is running the study
Any institutional affiliations
Why they are running the study

Background Information
•

Should Contain Information about:

•
•

Rationale for running the study
Purposes of the study

•

How the data collected will be used

39

Procedures

•

Should Contain Information about:

•
•
•

What participants will be asked to do
Descriptions of those activities
Time requirements

Risks and Benefits
•
Should Contain Information about:

•
•
•
•
•

Amount of Risk posed to participants
How to deal with potential risks
Description of Withdrawing Rights
How to withdrawal from the study
Description of Direct Benefits to participation

Compensation
•

Should Contain Information about:

•
•

Description of Direct Benefits
This may include financial rewards, organizational rewards, or academic rewards

Confidentiality
•

Should Contain Information about:

•

How records of data collected will be treated

•

How identifying information will be stored

•

Who will have access to data collected

•

Voluntary Nature of Participation
•

Should Contain Information about:

•
•
•

The Voluntary Nature of the Study
How withdrawing from the study will affect you
How to withdraw from the study

Contact Section

•

Should Contain Information about:

•

How to contact the researchers

•
•

How to contact the supervisor in charge
How to contact the relevant supervisory board
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Vignette E

There is nothing mysterious about Treatment 8. It's a natural method of health care
that focuses on treating the causes of physical problems and injuries, rather than just
the symptom. Treatment 8 is based on a simple but powerful premise: Your body has
the ability to heal itself if the important organs are healthy. Your important organs are
the main pathways of your important bodily system. Which in turn controls every
feeling, movement, and function throughout your body.
When the important bodily system is impaired by injury, stress, or illness it can cause
muscles, joints, and organs throughout the body to function poorly. This is why organ
8 is so important in maintaining pain free good health. Your organ 8 is a structure
designed for support and protection of the important bodily system. It is much like
the frame of your car. When the alignment is off, your car and its' engine do not run
as efficiently. The important bodily system is like your car's engine, very much
affected by the frame that houses it. Since your organ 8 can affect all parts of the
body, problems in your organ 8 can cause other problems, as well.
Because Treatment 8 treats the underlying causes of these problems rather than just
relieving symptoms, your body's natural healing process will work for you. The
Treatment 8 approach is to locate and correct problems with organ 8 that may cause
interferences to the important bodily system. These problems are corrected with
adjustments to increase the function of organ 8. Treatment 8 can improve organ 8's
strength, balance and mobility, while relieving pain and stiffness. After organ 8 has
regained mobility, we teach you ways that you can increase the strength of organ 8 to
prevent future damage from occurring.
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Use the Following 7-Point Scale to answer the questions.
1 2

3

4

5

6

7

Completely Disagree |
Some Disagree
Completely Agree
Mostly Disagree
Uncertain

Some Agree
Mostly

Agree
1.

I believe that Treatment X is effective in the treatment of Condition A.
12

2.

4

5

6

7

I would choose Treatment X if I had Condition A.
12

3.

3

3

4

5

6

7

If a friend or family member had Condition A, I would NOT recommend
Treatment X.

12

3

4

5

6
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After you read each medical claim vignettes please answer the following questions.
Authority:

Can you identify what person or organization is making the claim?
Yes

No

Irrelevant

Does the person or organization who is making the claim have anything to gain, such
as selling a product or a political ideology?
Yes

No

Irrelevant

Does the person or organization making the claim focus only on supportive evidence,
while ignoring or criticizing the source of contradictory evidence?
Yes

No

Irrelevant

Does this claim suggest their product or treatment is well known elsewhere
but actively hidden by stronger competitors here? For example, The secret cancer
treatments that Western Medicine doesn't want you to know about.
Yes

No

Irrelevant

Logic

Does this claim suggest that findings that are currently unexplained will never be
explainable?
Yes

No

Irrelevant

Does the person or organization making the claim suggest that the lack of
contradictory evidence is itself evidence that is contradictory? For example, There
are no studies demonstrating that the sun is not powered by a giant hamster wheel,
therefore the sun is powered by a giant hamster wheel.
Yes

No

Irrelevant

Does this claim place agreeing with them or disagreeing with them on two ends of a
spectrum even though they are not strictly opposites? For example, When it comes to
buying floral arrangements there are two kinds of people, those who love their
significant others and people who are cheap.
Yes

No

Irrelevant

Does the person or organization making the claim suggest that a small step in any
given direction , such as not purchasing their product or supporting a competitor,
leads down a path of catastrophic consequences?
Yes

No

Irrelevant

67

Non-evidence:

Does the claim present two events that happened to occur in sequence as though the
the first caused the second?
Yes

No

Irrelevant

Does this claim use personal anecdotes as a substitute for scientific research?
Yes

No

Irrelevant

Does this claim use enough personal anecdotes that they can substitute for research?
Yes

No

Irrelevant

Does the person or organization making the claim present the limitations or
contraindications for their product or treatment? For example, Antibiotics are great
for treating a bacterial infection, but they are below useless for viral infections.
Yes

No

Irrelevant

Language Use:

Does the person or organization making this claim hide behind complex words or
language to mask the lack of evidence behind their claim? For example, When asked
about the source of her powers, a local psychic explained that quantum mechanics
provide the power behind her clairvoyant abilities..
Yes

No

Irrelevant

Does this claim appeal to you emotionally when it should be appealing to your
rational side? For example, Only a hateful parent would refuse their children cod liver
oil.

Yes

No

Irrelevant

Does this claim attempt to bolster their claims by tearing down a poorly built version
of their opponents evidence? For example, It is clear to us that pigs may be made to
fly as our opponents have only used glue to attach the porcine wings. And never
staples, the lynchpin of the Dominic's Flying Pig construction process.
Yes

No

Irrelevant

Does the person or individual making the claim present their opponents as negative
caricatures or their arguments in a simplistic way? For example, Dr. Jergins only has
a PhD in behavior analysis. Even if he could manage to see past his facial hair and
operant chambers, he is not qualified to assess whether soap stone pendants can cure
cancer.

Yes

No

Irrelevant
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At the beginning of this study you went through an informed consent process.
1. How difficult do you think this consent procedure was?
1

2

3

I
Very Easy

4

5

I
Not Hard or Easy

6

7

I
Very Hard

2. How informed about this study do you feel as a result of this informed consent
process?
1

2

Not Informed at All

3

4

Somewhat Informed

5

6

7

Informed about All Aspects

3. How useful to you feel this informed consent procedure was?
1

2

3

Not Useful

4

5

Somewhat Useful

6

7

Very Useful

4. What is your overall impression of the informed consent process?
1

Very Negative

2

3

4

Neutral

5

6

Very Positive

Do you have any additional comments or suggestions about the informed consent
procedure?
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Thank you very much for your participation in this study!
The second goal of this study was presented in a purposefully vague way. Research
has documented deficiencies in the informed consent process of human subjects
research protocols. This study aims to compare two variations of informed consent
procedures in order to see which promotes better participant understanding. You have
been exposed to one of two situations as part of this study. Half of participants will go
through a standard consent procedure, where they were asked to read a consent form
and click a check box to indicate their consent to participate in this research study.
The second half of participants were shown a series of slides that contain information
on the rationale for gathering informed consent from research participants. The
second half were then asked to read sections of the consent document and then to

answer multiple choice questions about what they had read. All participants were then
asked to complete a short quiz about the information in the consent document.

I apologize for the deception. If participants had been informed on the intent to
measure the amount of information they remembered from the consent form, they
may have paid closer attention than if they had not been informed of this
measurement. Much the same way a student will focus their studying on material a
teacher says will be on a test.
The researcher would also like to reward you for your participation with the
following popular internet reward (Appendix R. Internet Based Compensation)

If you have any additional questions or concerns about this study please Contact the
researcher at: Michael.Reynolds@wmich.edu
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Consent Form
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Western Michigan University
Department of Psychology

Principal Investigator:
Student Investigator:
Title of Study:

Wayne Fuqua, PhD.
Michael Reynolds, MA.
Effects of a checklist on the believability of medical
claims, and an analysis of consent procedures.

You have been invited to participate in a research project titled "Effects ofa checklist
on the believability ofmedical claims, and an analysis ofconsent procedures." This
study is being conducted as part of the thesis requirement of the behavior analysis

program at Western Michigan University. This consent document will explain the
purpose of this research project and will go over all of the time commitments, the
procedures used in the study, and the risks and benefits of participating in this
researchproject. Please read this consent form carefully and completely and please
contact the researcher at michael.reynolds@wmich.edu if you have any questions.
What are we trying to find out in this study?
In our information intensive, media saturated world, we are bombarded every day
with lots of health related information and claims. Some of these health claims are

accurate but, unfortunately other claims are unproven or, in some cases, misleading.
The primary purpose of this study is to assess the effect on believability of medical
claims as result of exposure to an evidence checklist. A secondary purpose of this
study is to explore the effects of a modified consent procedure.
Who can participate in this study?

You are being invited to participate because you are either a student attending
Western Michigan University or clicked on the study's advertisement on Facebook©.
You must be over the age of 18 and have access to the internet to participate in this
study.

Where will this study take place?

This study is conducted over the internet at surveymonkey.com.
What is the time commitment for participating in this study?

This study will take about 60 minutes of your time, in a single session. It is not
possible to stop taking the survey halfway through and then come back to finish later.
What will you be asked to do if you choose to participate in this study?
If you agree to participate, we will ask you to: Read and respond to a series of nine
medical claim vignettes, complete an anonymous demographics survey, complete a
survey about your personal beliefs on a variety of topics, and be exposed to one of
two different consent procedures.
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What information is being measured during the study?

A variety of information is being collected in this study; Believability of medical
claims, demographic information, a profile of your personal beliefs, and the effects of
a modified consent procedure. All data collected will be used only for these purposes,
and will not be shared with any other persons or organizations.
What are the risks of participating in this study and how will these risks be
minimized?

There is slight risk to you for participation in this study. Some of the questions on the
personal beliefs survey may produce anxiety. For example several of the questions
will ask about beliefs of a spiritual or religious nature, while others ask about
supernatural creatures. This survey asks about a wide variety of beliefs and is not
intended to insult or judge any specific beliefs.
You have the right to withdraw from the study at anytime. If you choose to withdraw,
please close the browser window in which this form is displayed.
What are the benefits of participating in this study?
There is little to no direct benefit to you for participating in this study.
Are there any costs associated with participating in this study?
There is no cost to this study except for the time it takes to participate.
Is there any compensation for participating in this study?
There is minor compensation for completing this study, in the form of an animated
gif. file of a cat hugging a teddy bear. This image is presented after one has
completed this study, which may be around one hour after one has begun.
Who will have access to the information collected during this study?

The information collected from you is completely anonymous. There is no way to
link the information collected with you. The information will be stored on
surveymonkey.com's servers until the end of data collection (See
www.surveymonkey.com for information on their security procedures). Following
data collection, information will be stored on a password protected computer in the
behavior medicine lab for seven years. If you choose to withdraw from the study,
your data will not be included for analysis.
What if you want to stop participating in this study?
You can choose to stop participating in the study at anytime for any reason. You will
not suffer any prejudice or penalty by your decision to stop your participation. You
will experience NO consequences either academically or personally if you choose to
withdraw from this study. To accomplish this, simply close the browser that contains
the survey.
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Who should I contact if I have Questions?

If you have any questions now, during, or after completion of the study, you are
encouraged to contact the researcher at Western Michigan University, Wood Hall
Suite 3700, 269.387.4500 (Psychology Department Office) or by email at
Michael.Reynolds@wmich.edu. To contact Wayne Fuqua, the supervisor of this
study, call 269.387.4474 or email him at wayne.fuqua@wmich.edu. You may also
contact the Human Subjects Institutional Review Board at 269-387-8293 or the Vice
President for Research at Western Michigan University, Dr. Dan Litynski, at 269387-8298 if questions arise during the course of the study.
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Study Compensation
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A five second animated .gif file of a cat hugging a tiny stuffed teddy bear.

Source of Image: http://i.imgur.com/5CJbl.gif
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Appendix O

Human Subjects Review Board Approval Notification
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Date: April 12,2011

To:

Wayne Fuqua, Principal Investigator
Michael Reynolds, Student Investigator for thesis

From: Amy Naugle, Ph.D., Chair
Re:

HSIRB Project Number 11 -04-08

This letter will serve as confirmation that your research project titled "Testing a
Procedure to Promote Participant Understanding of Informed Consent Documents
with a Linked Research Project on the Believability of Medical Claims" has been
approved under the exempt category of review by the Human Subjects Institutional
Review Board. The conditions and duration of this approval are specified in the
Policies of Western Michigan University. You may now begin to implement the
research as described in the application.

Please note that you may only conduct this research exactly in the form it was
approved. You must seek specific board approval for any changes in this project.
You must also seek reapproval if the project extends beyond the termination date
noted below. In addition if there are any unanticipated adverse reactions or
unanticipated events associated with the conduct of this research, you should
immediately suspend the project and contact the Chair of the HSIRB for consultation.
The Board wishes you success in the pursuit of your research goals.

Approval Termination:

April 12, 2012
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Table 1. Group Performance on End-of-Study Informed Consent Comprehension Test
Group 1 Label
Group 2 Label
n
Mean
Comparison
n
Mean
F
P
Control
Experimental
78.71
26
31
92.9 21.22 <001
Control vs. Experimental
Women

Men

Gender within Control

17

80.39

8

74.16

0.54

0.58

Gender within Experimental

20

92.33

11

93.93

0.44

0.515

16

75.83

1.44

0.243

10

94

0.95

0.39

High GPA
GPA within Control

GPA within Experimental

Low GPA

10

83.33

20

92

High Belief
Paranormal Beliefs within

Low Belief

17

77.64

9

11

91.51

20

80.74 0.222

0.642

93.66

0.79

0.381

Contra I
Paranormal Beliefs within

Experimenta I
High Discrepancy
Medical Beliefs within

Low Discrepancy

r

9

82.96

17

76.47

1.01

0.325

20

93

11

92.72

0.01

0.912

Control
Medical Beliefs within

Experimental
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Table 2. Participant Satisfaction with Consent Procedures
Cumulative Percentages
Experimental Group

Control Group
Ease of Use

Very easy

53.8

Not hard or easy

Very hard

58.1

19.2

29

7.7

3.2

11.5

6.5

0

3.2

0

0

0

0

Informed as a Result
Not informed at all

Somewhat informed

Informed about all aspects

0

0

0

0

11.5

9.7

19.2

6.5

7.7

9.7

30.8

19.4

30.8

54.8

0

0

Usefulness of Procedure
Not Useful

Somewhat Useful

Very Useful
Overall Impression
Very Negative

Neutral

Very Positive
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0

0

15.4

9.7

23.1

12.9

3.8

25.8

46.2

22.6

7.7

23

0

0

0

3.2

3.8

12.9

26.9

9.7

19.2

3.2

15.4

35.5

34.6

35.5

Appendix C
Informed Consent Comprehension Test Form 1
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1. What groups were invited to participate in the current study?
a. College Students and Facebook users*
b. Employed Adults and Facebook users

c .Michigan State Workers and Employed Students
d. Internet Users and Highschool Students
2. Which of the following is a purpose of this study?
a. Test a new PTSD survey
b. Assess differences in Medical Claims *

c. Test a Therapy Technique
d. Assess effects of Text Coloring

3. What will the data you provide be used for?
a. Testing the Effectiveness of Internet Surveys

b. To develop New Course Curriculum
c. Solely for the Purposes of this Study *
d. Track Personal Purchasing Habits

4. Which of the following will you be/were you asked to complete?
a. A PTSD Survey

b. A Personality Inventory
c. A Sexual Health History Survey

d. A questionnaire about Medical Claims *
5. What is the expected amount of risk to you should you choose to participate?
a. Monetary Risk
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b. Severe Risk

c. Slight Risk *
d. Minimal Risk

6. When are you allowed to withdraw from this study?
a. Only at the Beginning
b. At Any Time*
c. Only at the End

d. At specific times as Prompted

7. What compensation is there for you if you participate?
a. An Animated Gif *
b. Five Dollars

c. A Personality Profile

d. Coupons to a Local Pizzeria
8. Could someone use the data you provide to identify you?

a. Yes, but only if I choose to be identified
b. No, the data could not be used to identify me *
c. No, the data will not be stored

d. Yes, the data will be used to identify me
9. Who will have access to the data you provide?
a. No one as the data will not be stored

b. The Staff of Survey Monkey

c. Only the Researcher and their Principle Investigator *
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d. All members of the WMU Psychology Faculty

10. Which relationships will be affected if you decide against participating or
withdraw from this study?

a. My Relationship with my Professors, unless I explain why I withdrew.
b. My Relationship with Western Michigan University
c. My Relationship with the Researchers

d. No Relationships will be Affected by Withdrawing from this Study *
11. Who is running this study?
a. Lynn Stage
b. Clifford Galindo

c. Michael Reynolds *
d. Naomi Ellis

12. Who is supervising this study?
a. Lydia Tate MsW

b. Wayne Fuqua PhD*
c. Maria Hornbeck PhD
d. Marco Tovar Eds

13. Where would you go if you wanted to speak with the Researchers?
a. Wood Hall Suite 3700 *
b. Bernhard Center Room 2230
c. Geraldine Tower Suite 12

d. Haenicke Hall Room 1897
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14. If you want to express some concern or ask a question of someone other than
the researchers, who should you contact?

a. Harry Murphy, President of Researcher Relations
b. Dan Litynski, Vice-President of Research *
c. Rose Mohan, Head of Human Participant Concerns
d. Emma Steele, Assistant Chair of Scientific Conduct

15. With which University are the researchers affiliated?
a. Michigan State University
b. Western Oklahoma State University

c. Western Michigan University *
d. University of Minnesota
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Informed Consent Comprehension Test Form 2
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1. Are you participating in this study as part of a job requirement?
a. No, Participation is entirely voluntary *
b. Yes. Participation is required by my employer.

c .No. This study is one of several options available to me.
d. Yes. Participation is required to complete a training seminar.
2. Which of the following is a purpose of this study?
a. Test a depression survey
b. Assess differences in Consent Procedures*

c. Test a New Therapy
d. Assess effects of Video-Enhanced Presentations

3. What will the data you provide be used for?

a. As part of a research requirement for an employee training program.
b. To develop New Course Curriculum

c. As part of the thesis requirement at Western Michigan University *
d. Track Personal Internet Habits

4. Which of the following were you asked to complete?
a. An Anxiety Survey
b. A Drug History Inventory
c. A Life History Survey

d. A questionnaire about Personal Beliefs*
5. Why is there the possibility of a slight amount of risk for this experiment?
a. Risk of side effects from computer exposure
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b. There is no risk to participation in this study

c. Anxiety from A Personal Belief Survey *
d. Exposure to Medical Vignettes
6. How does one withdraw from this study?

a. Contact the Research Supervisor
b. Close the Browser Window*

c. Seek help from Institutional IT support
d. Use the withdraw from study form

7. What compensation is there to participation in this study?
a. An animated Gif5

b. 1 dollar per Survey

c. Treatment for Depression Symptoms

d. A gift card to a local home improvement store
8. Will the Data collected be used to Identify you?

a. Yes, but only if I choose to receive information about the results
b. No, the data could not be used to identify me *
c. No, the data will not be stored

d. Yes, the data will be used to send me coupons to a pizzeria

9. Will just anyone have access to your data?
a. No, the data will not be stored

b. No, Only Institutional IT Support Staff

c. No, just the Researchers conducting the study *
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d. Yes, Your data is public record

10. Would Withdrawing from this study negatively your professional
relationships ?

a. Yes, My Relationship with my Professors will be negatively affected
b. No, My professional Relationship will be improved by withdrawing
c. Yes, My Relationship with the Researchers will be negatively affected
d. No Relationships will be Affected negatively by Withdrawing from this Study *
11. Who is running this study?

a. Richard Claypool, Graduate Student at WMU
b. Clifford Galindo, Employee Trainer at Comtech
c. Michael Reynolds, Graduate Student at WMU *
d. Jerry Allen, Manager at Allied Healthcare Management
12. Who is supervising this study?

a. Lydia Tate MsW, Trainer at Allied Healthcare Management

b. Wayne Fuqua PhD, Faculty Member at Western Michigan University*
c. Maria Hornbeck PhD, Manager at Comtech

d. Marco Tovar Eds, Faculty Member at Western Michigan University
13. Where can you contact the researchers with questions?

a. 269.387.4500, Psychology Department Office *
b. 269.387.5270, Sociology Department Office
c. 586.630.5009, Allied Healthcare Management
d. 313.915.3125, Comtech Industrial

49

14. If you want to express some concern or ask a question of someone other than
the researchers, who should you contact?

a. Allied Healthcare Management,Research Hotline, 312.276.8579

b. Human Subjects Review Board, 269.387.8293 *
c. Institutional Animal Care and Use Committee, 269.387.5634

d. Comtech Industrial Research Advocacy Line, 267.435.5224

15. With which University are the researchers affiliated?
a. Purdue University

b. Western Oklahoma State University

c. Western Michigan University *
d. University of Michigan
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Demographic Survey
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Appendix F
Revised Paranormal Belief Scale
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Please circle the number next to each item to indicate how much you agree or

disagree with that item. Use the numbers as indicated below.
There are no right or wrong answers! This is a sample of your own beliefs and
attitudes.

This study does not presuppose that beliefs are correct or incorrect, rather that
individuals differ in what beliefs they have.
12

3

4

5

6

7

Strongly

Moderately

Slightly

Strongly
Disagree

Disagree

Disagree

Uncertain

Slightly
Agree

Moderately
Agree

Agree

1. The soul continues to exist though the body may die.
12 3 4 5 6 7

2. Some individuals are able to levitate (lift) objects through mental forces.
12 3 4 5 6 7

3. Black Magic exists.
12 3 4 5 6 7

4. Black cats can bring bad luck.
12 3 4 5 6 7

5. Your mind or soul can leave your body and travel (astral projection).
12 3 4 5 6 7

6. The abominable snowman of Tibet exists.
12 3 4 5 6 7

7. Astrology is a way to accurately predict the future.
12 3 4 5 6 7

8. There is a devil.
12 3 4 5 6 7

9. Psychokinesis, the movement of objects through psychic powers, does exist.
12 3 4 5 6 7

10. Witches do exist.
12 3 4 5 6 7

11. If you break a mirror, you will have bad luck.
12 3 4 5 6 7

12. During altered states, such as sleep or trances, the spirit can leave the body.
12 3 4 5 6 7

13. The Loch Ness monster of Scotland Exists.
12 3 4 5 6 7

14. The horoscope accurately tells a person's future.
12 3 4 5 6 7

15. There is a God.
12 3 4 5 6 7
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16. A person's thoughts can influence the movement of a physical object.
12 3 4 5 6 7

17. Through the use of formulas and incantations, it is possible to cast spells on
people.
12 3 4 5 6 7

18. The number "13" is unlucky.
12 3 4 5 6 7

19. Reincarnation does occur.
12 3 4 5 6 7

20. There is life on other planets.
12 3 4 5 6 7

21. Some psychics can accurately predict the future.
12 3 4 5 6 7

22. There is a heaven and a hell.
12 3 4 5 6 7

23. Mind reading is not possible
12 3 4 5 6 7

24. There are actual cases of witchcraft.
12 3 4 5 6 7

25. It is possible to communicate with the dead.
12 3 4 5 6 7

26. Some people have an unexplained ability to predict the future.
12 3 4 5 6 7
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Personal Belief Scale
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27. Magnetic Bracelets are effective at providing relief from pain.
12 3 4 5 6 7

28. It is possible to improve one's quality of life by cleansing toxins from one's body.
12 3 4 5 6 7

29. A gluten free diet can alleviate cognitive impairment in children.
12 3 4 5 6 7

30. Childhood Vaccines can cause cognitive impairment.
12 3 4 5 6 7

31. Chiropractic Adjustment is able to prevent bone diseases.
12 3 4 5 6 7

32. Massage is effective at providing stress relief.
12 3 4 5 6 7

33. Acupuncture is an effective strategy for relaxation.
12 3 4 5 6 7

34. Antibiotics can reduce the time to recover from bacterial infections.
12 3 4 5 6 7

35. Therapeutic Touch can balance and promote the flow of human energy.
12 3 4 5 6 7

36. One can reduce the length of a cold by taking more than the daily- recommended
dosages of basic vitamins.
12 3 4 5 6 7

37. Dietary changes can affect a person's cholesterol levels.
12 3 4 5 6 7

38. Regular exercise can alleviate feelings of depression.
12 3 4 5 6 7

39. One can recover lost memories from childhood through regression therapy.
12 3 4 5 6 7

40. Hypnotic suggestion is an effective way to bring about weight loss.
12 3 4 5 6 7

41. The analysis of dreams can provide meaningful solutions to life stressors.
12 3 4 5 6 7
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Vignette A

Today, there are numerous medical doctors, naturopaths, chiropractors, salons, spas,
massage therapists and other health care providers who practice Treatment 2. Treatment 2
is more comfortable and less invasive than conventional treatments. Why pay $25-75 for
this service when you can easily do it at home? The benefits have been documented
through case histories by qualified practitioners. The benefits include, improved hearing,
vision, taste, smell, balance and sharpened mental ability. Treatment 2 helps to detoxify
the sinus, lymph congestion, sore throat, earache, swimmers ear, chronic headaches and
even allergies. Every body is different, yet Treatment 2 is a therapy that adults, children,
and even animals can benefit from. There is absolutely no discomfort during this process.

If you experience any pain while during Treatment 2, stop immediately, as this is an
indication of a more serious problem than Treatment 2 can address. Treatment 2 is safe
and painless; some people become so relaxed they fall asleep during the treatment.
Treatment 2 is not a cure-all, but has proven to be a successful and economic alternative
to having other conventional medical treatments. The non-invasive Treatment 2 process
has been known to improve hearing, lymph circulation, and balance. Our clients report
relief from tinnitus, vertigo, and pressure regulation.

Treatment 2 is especially indicated for people who suffer from allergies, hay fever,
asthma, etc. due to the bees interaction with the plant environment. As an added benefit,
Treatment 2 has a pleasant aroma and have a very soothing effect. Relaxation is an

important part of the Treatment 2 process. All who experience Treatment 2 agree it is
safe, soothing, relaxing, painless, and non-invasive.
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Vignette B

The genius' breakthrough is one in which he or she escapes the rigidities of the
normal and tired patterns of thought—unconventionality is one great measure of
brilliance. One such example of an all-natural product of unconventional (but no
doubt effective) thought is the concept of Treatment 4 by Brand Zero.

Treatment4 is a very effective treatment which uses only natural herbs, allowing for
the body's complete response to Condition 4. Spoke S. Person, who is almost a
century old, is the eager spokesperson of the product, and thus becomes the perfect
testament for Treatment 4 claim to healthy living.

Each portion of Treatment 4 contains vegetable fiber, vitamin C, dextrin, loquat
leaves, chitosan, tourmalines, houttuynia coddata, and bamboo and wood vinegar.
Treatment 4 is manufactured in Asia where most of its natural ingredients are

harvested. Treatment 4 is applied to the area affected by Condition 4 at least 8 hours

every night, although sometimes longerapplications might be necessary depending
on an individual's body chemistry. The aforementioned ingredients then all work

together, to help the body alleviate the cause of Condition 4. Quite simply, Treatment
4 works.
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Vignette C
Naturally occurring treatment with specific properties is called treatment 6, a
treatment traditionally worn to guard against condition 6 and to instill a sober mind.
The name of treatment 6 comes from the Greek meaning 'without condition 6' and
treatment 6 is believed to protect one from poison.

It is used as a dream promotion agent and to help insomnia. Put treatment 6 under
your pillow to bring about pleasant dreams, or rub it across your forehead to offer
relief from condition 6.

Ancient Civilization 6 used treatment 6 to guard against guilty and fearful feelings. It
has been worn as protection from self-deception, as well as a protection against
witchcraft. Treatment 6 has long been used to open the spiritual and psychic centers,
making it one of the power treatments. It is also used as a meditation aid when worn
as a necklace.

Treatment 6 is often worn by healers, as it has the power to focus energy. A healer
will usually wear several pieces ofjewelry with treatment 6 set in silver, especially a
treatment 6 necklace. The person to be healed will have treatment 6 to hold while the
healing is being done. The healer will place another piece of treatment 6 on the area
of the body in need of healing, the important organs usually.

Treatment 6 is used for problems in two important bodily systems. Pieces of
treatment 6 are used to keep the air and life force in the home clean and positive.
Pieces of treatment 6 placed in a window that receives sun most of the day are very
beneficial to use in healing and to heal negativity in the home. Place treatment 6 in
moonlight and everyone in the home will be feeling calmer. Using treatment 6 as a
meditation focus will increase the positive spiritual feelings. Treatment 6 helps
overcome fears and cravings.
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Vignette D

Treatment 7 is a contemporary healing modality drawn from ancient practices and
developed by Expert A and Expert B. The practice is based on the assumptions that
human beings are complex internal systems, and that the ability to enhance healing in
another is a natural potential.
Treatment 7 is used to balance and promote the function of internal systems. It is
taught in colleges around the world and has a substantial base of formal and clinical
research. This research has shown that Treatment 7 is useful in reducing pain,
improving wound healing, aiding relaxation, and easing the dying process. It can be
learned by anyone with a sincere interest and motivation towards helping others.
Treatment 7 started at Location 7, a gathering site of Organization 7 in the foothills of
the mountain range in State 7. It was preceded by the work of Expert A who had a
highly developed sensitivity. Through the use of this natural ability she was able to
perceive blockages and dysrhythms in a patient's internal systems, subtle
disharmonies not accessible to other medical technologies. Expert A diagnosed
numerous perplexing cases referred by physicians and other scientists and often
suggested treatments and resources for her patients.

Expert A's abilities extended beyond the usual awareness of internal systems. For
example, she was particularly known for her work with the internal systems in an
individual. Since childhood Expert A was aware of such systems, and she made a
lifetime study of how they work and how they relate to attitudes and emotions, this
awareness later evolved into an understanding of the external system from which both
healers and patients can draw improved function of internal systems.
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